Related Experiment Video
Updated: Sep 6, 2025
08:10
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
7.9K
Molecular Biologic Milieu in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy: A Literature
Konstantinos Ananikas1, Panagiotis Stavrakas2, Christos Kroupis3
12nd Department of Ophthalmology, Attikon Hospital, University of Athens, Athens, Greece.
Ophthalmic Research
|June 23, 2022
Summary
Inflammation and immune responses are key in retinal detachment (RRD) and proliferative vitreoretinopathy (PVR). Understanding vitreous and subretinal fluid signaling molecules offers insights into pathophysiology and potential therapeutic targets.
Area of Science:
- Ophthalmology
- Immunology
- Pathophysiology
Background:
- Rhegmatogenous retinal detachment (RRD) and proliferative vitreoretinopathy (PVR) involve complex biological processes.
- Evidence suggests a significant role for immunological responses and inflammation in RRD and PVR development.
Purpose of the Study:
- To update knowledge on signaling molecules in vitreous and subretinal fluid (SRF) implicated in RRD and PVR.
- To review the immunological and inflammatory mediators involved in these retinal conditions.
Main Methods:
- A comprehensive literature search was conducted in the PubMed database up to November 2021.
- Included were papers on inflammatory/immunological mediators in primary RRD and PVR, analyzing cohort studies and reference lists.
Main Results:
- Significant evidence confirms the involvement of various signaling molecules in RRD and PVR pathophysiology.
- Disruption of normal equilibrium in vitreous and SRF points to the role of these mediators.
- Cytokines, chemokines, and growth factors are implicated, though their precise roles require further elucidation.
Conclusions:
- Immunological and inflammatory signaling molecules are broadly implicated in both primary RRD and PVR.
- Understanding the pathological milieu aids in identifying potential therapeutic targets for RRD and PVR.
- Further research is needed to address unmet needs and clarify the exact roles of these signaling molecules.
